University of Stirling, Stirling, Scotland, UK.
Robert Gordon University, Aberdeen, Scotland, UK.
Artif Intell Med. 2020 Jan;102:101759. doi: 10.1016/j.artmed.2019.101759. Epub 2019 Nov 17.
Antibiotic resistance is one of the major challenges we face in modern times. Antibiotic use, especially their overuse, is the single most important driver of antibiotic resistance. Efforts have been made to reduce unnecessary drug prescriptions, but limited work is devoted to optimising dosage regimes when they are prescribed. The design of antibiotic treatments can be formulated as an optimisation problem where candidate solutions are encoded as vectors of dosages per day. The formulation naturally gives rise to competing objectives, as we want to maximise the treatment effectiveness while minimising the total drug use, the treatment duration and the concentration of antibiotic experienced by the patient. This article combines a recent mathematical model of bacterial growth including both susceptible and resistant bacteria, with a multi-objective evolutionary algorithm in order to automatically design successful antibiotic treatments. We consider alternative formulations combining relevant objectives and constraints. Our approach obtains shorter treatments, with improved success rates and smaller amounts of drug than the standard practice of administering daily fixed doses. These new treatments consistently involve a higher initial dose followed by lower tapered doses.
抗生素耐药性是我们在现代社会面临的主要挑战之一。抗生素的使用,尤其是过度使用,是抗生素耐药性的唯一最重要的驱动因素。人们已经努力减少不必要的药物处方,但在开具处方时,优化剂量方案的工作有限。抗生素治疗的设计可以被制定为一个优化问题,候选解决方案被编码为每天的剂量向量。这种方案自然会产生相互竞争的目标,因为我们既要最大化治疗效果,又要最小化总药物使用量、治疗持续时间和患者经历的抗生素浓度。本文结合了最近的一个包括敏感菌和耐药菌的细菌生长数学模型,以及一个多目标进化算法,以便自动设计成功的抗生素治疗方案。我们考虑了结合相关目标和约束的替代方案。我们的方法获得了更短的治疗时间,提高了成功率,并减少了药物的使用量,优于每天固定剂量的标准治疗方法。这些新的治疗方案通常包括较高的初始剂量,然后是逐渐减少的剂量。